Cargando…
Urovysion FISH Could Be Effective and Useful Method to Confirm the Identity of Cultured Circulating Tumor Cells from Bladder Cancer Patients
Objective: To explore whether cultured CTC from bladder-cancer patients originate from bladder cancer and share chromosomal abnormalities, by means of a fluorescence in situ hybridization (FISH) test. Methods: A total of 15 ml of blood was collected from the patients with bladder cancer before treat...
Autores principales: | Kim, Tae-Jung, Moon, Hyong Woo, Kang, Sungmin, Yang, Jonghyup, Hong, Sung-Hoo, Lee, Ji Youl, Ha, U-syn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6603370/ https://www.ncbi.nlm.nih.gov/pubmed/31289598 http://dx.doi.org/10.7150/jca.30079 |
Ejemplares similares
-
Distinct mutation profiles between primary bladder cancer and circulating tumor cells warrant the use of circulating tumors cells as cellular resource for mutation follow-up
por: Kim, Tae-Min, et al.
Publicado: (2020) -
UroVysion fluorescence in situ hybridization (UroVysion FISH) assay for detection of bladder cancer in voided urine of Turkish patients: a preliminary study
por: Dodurga, Yavuz, et al.
Publicado: (2013) -
A prospective comparison of UroVysion FISH and urine cytology in bladder cancer detection
por: Lavery, Hugh J., et al.
Publicado: (2017) -
Gonadotropin-releasing hormone agonists, anti-androgens and the risk of cardio-cerebrovascular disease in prostate cancer patients: an asian population-based observational study
por: Seong, Jong-Mi, et al.
Publicado: (2020) -
Evaluation of UroVysion for Urachal Carcinoma Detection
por: Hu, Zhiquan, et al.
Publicado: (2020)